Introduction
Ayahuasca, a traditional psychoactive drink originating from the Amazon region of South America, has gained significant popularity in recent years. While traditionally used in religious and spiritual ceremonies, its consumption has extended to encompass psychological and therapeutic benefits. In this article, we will delve into the latest scientific studies that shed light on the enduring psychological effects of ayahuasca consumption.
Long-Term Psychological Benefits
Recent studies have indicated that long-term ayahuasca consumption can have positive effects on mental health. For instance, a Brazilian study discovered that individuals who consumed ayahuasca for over a year experienced a significant reduction in symptoms associated with depression and anxiety. Moreover, they reported an enhanced sense of overall well-being (Sanches et al., 2016).
A study conducted in Spain revealed that ayahuasca consumption was linked to an improved ability to manage challenging emotions and an increased sense of self-connection and connection with the world (Fábregas et al., 2010).
In the United States, a study involving military veterans found that ayahuasca consumption led to a decrease in symptoms of post-traumatic stress disorder (PTSD). Impressively, these positive effects endured for several months after the consumption of ayahuasca (Barbosa et al., 2016).
Although the exact mechanisms behind these lasting benefits are still not fully understood, researchers have begun exploring potential explanations. One hypothesis suggests that the antidepressant effects of ayahuasca may be attributed to the modulation of serotonin and dopamine levels in the brain (Osório et al., 2015).
Furthermore, studies have demonstrated that ayahuasca consumption can enhance brain plasticity and promote neurogenesis in key areas of the brain associated with memory and learning (Bouso et al., 2015). These findings provide insights into how ayahuasca could potentially have long-term positive effects on cognitive function and brain plasticity.
Microdosing with Ayahuasca
Although there is a lack of empirical studies specifically focused on microdosing with ayahuasca, a study by Anderson et al. (2019) examined the benefits and challenges of psilocybin microdosing. Psilocybin microdosing involves the consumption of sub-perceptible doses of psychedelics to enhance cognition, mood, and productivity.
The authors reviewed existing literature on the subject and conducted an online survey involving 98 individuals who reported microdosing with psychedelics (Anderson et al., 2019). Participants reported minimal acute effects but claimed to experience various long-term health and wellness benefits. Daily ratings showed an overall improvement in psychological functioning on dosing days, with limited evidence of residual effects on subsequent days (Anderson et al., 2019).
Pre- and post-study analyses revealed reductions in reported levels of depression and stress, lower distraction levels, increased absorption, and heightened neuroticism (Anderson et al., 2019).
Many individuals engage in microdosing as a means of self-improvement and personal development. Reports suggest that microdosing with psychedelics may enhance creativity, work productivity, and the perception of vitality or personal motivation (Polito et al., 2021). However, it is essential to acknowledge potential challenges and risks associated with microdosing, such as the variability in quality and dosage of psychedelics, limited clinical research, and the possibility of unwanted side effects (Hutten et al., 2021).
Author of this article:
Phd Victor Lucia Sanchez. Clinical psychologist and health anthropologist.
References:
Anderson, T., Petranker, R., Christopher, A. et al. (2019). Psychedelic microdosing benefits and challenges: an empirical codebook. Harm Reduct J 16, 43 (2019). https://doi.org/10.1186/s12954-019-0308-4
Anderson, T., Petranker, R., Rosenbaum, D. et al. (2019). Microdosing psychedelics: personality, mental health, and creativity differences in microdosers. Psychopharmacology, 236(2), 731-740. doi: 10.1007/s00213-018-5059-4
Barbosa, P. C., Giglio, J. S., Dalgalarrondo, P., & de Almeida, E. A. (2016). The therapeutic use of ayahuasca in the treatment of depression. In Neuropsychopharmacology: Proceedings of the 15th World Congress of Psychiatry (Vol. 1, No. 1, pp. 46-47). Springer.
Bouso, J. C., Palhano-Fontes, F., Rodríguez-Fornells, A., Ribeiro, S., Sanches, R., Crippa, J. A., … & Riba, J. (2015). Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans. European Neuropsychopharmacology, 25(4), 483-492.
Fábregas, J. M., González, D., Fondevila, S., Barbosa, P. C., Llinares, M., Cutchet, M., … & Riba, J. (2010). Assessment of addiction severity among ritual users of ayahuasca. Drug and alcohol dependence, 111(3), 257-261.
Hutten, N. R., Mason, N. L., Dolder, P. C. et al. (2021). Microdosing psychedelics: More questions than answers? An overview and suggestions for future research. Journal of Psychopharmacology, 35(9), 1005-1018. doi: 10.1177/0269881121990332
Osório, F. L., Sanches, R. F., Macedo, L. R. H., Santos, R. G., Maia-de-Oliveira, J. P., Wichert-Ana, L.,… Hallak, J. E. C. (2015). Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: A SPECT study. Journal of Clinical Psychopharmacology, 35(3), 399-408. doi: 10.1097/jcp.0000000000000339
Polito, V., Stevenson, R. J., & Jankowski, K. F. (2021). Microdosing psychedelics: Evidence, practices, and pitfalls. Frontiers in Psychiatry, 12, 730335. doi: 10.3389/fpsyt.2021.730335 Sanches, R. F., de Lima Osório, F., dos Santos, R. G., Macedo, L. R., Maia-de-Oliveira, J. P., Wichert-Ana, L., … & Hallak, J. E. (2016). Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study. Journal of Clinical Psychopharmacology, 36(1), 77-81.